← FDA Drug Approvals (Drugs@FDA)

LOCHOLEST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 1996-08-15

Drug application

FDA Application #

ANDA074561

Application type

Abbreviated New Drug Application (Generic)

Brand name

LOCHOLEST

Generic name

CHOLESTYRAMINE FOR ORAL SUSPENSION

Active ingredients

CHOLESTYRAMINE

Dosage form

POWDER

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL RX

Manufacturer

Chartwell RX, LLC

First approval

1996-08-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown